|
 |
2nd Annual International Cannabinoid-Derived Pharmaceuticals Summit (description) "" | Category: | Health & Wellness | Address: | 401-403 D Street Boston, Massachusetts, United States of America 02210 | Phone: | | Event dates: | 9/10/2019 - 9/12/2019 (This event has already taken place) | Event web site: | http://go.evvnt.com/432307-0?pid=5188 | findCE GPA: | This event is not yet rated. Click here to view a sample report card Click here to rate 2nd Annual International Cannabinoid-Derived Pharmaceuticals Summit |
|
Speakers/Presenters: | Topics to be Covered: | - Guy Chamberland, Chief Executive Officer, Tetra Biopharma, Dennis Ahern, Vice President, Global Regulatory Affairs, Greenwich Biosciences, Mara Gordon, Founder & Director, Zelda Therapeutics, Brian Murphy, Chief Executive Officer, Emerald Biopharma, Sara Ward, Researcher, Oncology, Temple University, Ethan Russo, Professor, International Cannabis and Cannabinoids Institute, Andrea Small-Howard, Chief Science Officer, GB Sciences, Robert Walsh, Chief of Regulatory Affairs Branch Division of Therapeutics & Medical Consequences of Drug Abuse,NIDA, Sagnik Bhattacharyya, Reader of Translational Neuroscience & Psychiatry, King's College London
| |
Contact: | info@hansonwade.com | Organizer phone: | | Offering type: | Data not provided | Specialty: | Data not provided | Event frequency: | Never | First Meeting: | | Total events: | | Est. attendance: | |
| Target audience: | Any | Other target audiences: | | Host Sponsor: | Hanson Wade | Est. # of exhibitors: | | Currency: | US Dollars | Language: | English | CE Credits: | | Organizer URL | |
|
Description:Following the success of the first iCDP summit last year, we are returning this September to provide the primary industry platform for the advancement of cannabinoid-derived pharmaceuticals. When this summit takes place it will have been just over a year since GW Pharmaceutical's created the first FDA approved drug containing a cannabinoid API, and several contenders are hot on their heels. However, there are many challenges still obstructing the development of this generation of cannabinoid pharmaceuticals.
Join your peers at the 2nd Annual International Cannabinoid-Derived Pharmaceuticals Summit to solve your challenges in this fast growing field, and to maximise the potential of the next-generation of cannabinoid pharmaceuticals.
*Early booking and group discounts are available upon request. For more details visit our website for the full pricing list. Schedule:08:20 - 16:10 Registration Fee Details:Conference + 2 Workshops: USD 3097.0, Conference + 1 Workshops: USD 2598.0, Conference Only: USD 2099.0, Workshops Only: USD 599.0Other items that tuition includes:Travel and hotel arrangements:
Contact Person: | Customer Services | Contact Email | info@hansonwade.com | Organizer State/Province: (Outside US) | | Organizer Country | Data not provided | Structural makeup | Data not provided | Host Sponsor; Other Sponsors | Hanson Wade | Event Site/Venue | Aloft Boston Seaport District | Event sold out? | No | Multiple locations or dates? | No | Statistics available for most recent event held in: | NA | Average number in event attendance of: | | Range: | | Number in attendance of: | | Range: | | Target Boundaries | Local | Is Registration contact information the same as Organizer Contact above? | Yes | Web Page | https://go.evvnt.com/432307-2?pid=5188 | Can one register for your CE on your web site? | NA | Can registration be made by snail (regular) mail? | Yes | Online housing reservations: |
| Do you have additional written or AV materials for sale? | No | If so, are they available for non-attendees as well as those attending? | NA | Is full tuition necessary to ensure registration? | No | Will there be shuttle service available? | NA |
|
 |
|